[ Back to EurekAlert! ]

Contact: Robbin Ray
Robbin_Ray@dfci.harvard.edu
617-632-4090
Dana-Farber Cancer Institute

Pasi A. Janne, MD, Ph.D., Dana-Farber Cancer Institute

Caption: A new study by researchers including Dr. Pasi A. Janne reports first success of targeted therapy in most common genetic subtype of non-small cell lung cancer

Credit: Dana-Farber Cancer Institute

Usage Restrictions: None

Related news release: Researchers report first success of targeted therapy in most common non-small cell lung cancer


[ Back to EurekAlert! ]